Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karine Breckpot

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets|October 28, 2009
Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modificationKarine Breckpot, David Escors
Frontiers in Immunology|September 27, 2018
The Journey of <i>in vivo</i> Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy RoadCleo Goyvaerts, Karine Breckpot
Nature Biomedical Engineering|April 3, 2019
Towards a personalized iPSC-based vaccineCleo Goyvaerts, Karine Breckpot
Archivum Immunologiae Et Therapiae Experimentalis|February 10, 2010
Lentiviral vectors in gene therapy: their current status and future potentialDavid Escors, Karine Breckpot
Journal of Immunology Research|November 20, 2015
Pros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesCleo Goyvaerts, Karine Breckpot
Frontiers in Cell and Developmental Biology|August 17, 2019
Commentary: Immunogenic Cell Death and Immunotherapy of Multiple MyelomaKen Maes, Karine Breckpot
International Review of Cell and Molecular Biology|January 15, 2024
Novel technologies for applying immune checkpoint blockersRobin Maximilian Awad, Karine Breckpot
Immunotherapy|May 11, 2011
mRNA: delivering an antitumor message?Sandra Van Lint, Kris Thielemans, Karine Breckpot
Current Gene Therapy|December 17, 2008
Lentiviral vectors for anti-tumor immunotherapyKarine Breckpot, Perpetua U Emeagi, Kris Thielemans
Oncoimmunology|November 20, 2012
The role of SMAC mimetics in regulation of tumor cell death and immunityPerpetua U Emeagi, Kris Thielemans, Karine Breckpot
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Endocrine, Metabolic & Immune Disorders Drug Targets|October 28, 2009
Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modificationKarine Breckpot, David Escors
Frontiers in Immunology|September 27, 2018
The Journey of <i>in vivo</i> Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy RoadCleo Goyvaerts, Karine Breckpot
Nature Biomedical Engineering|April 3, 2019
Towards a personalized iPSC-based vaccineCleo Goyvaerts, Karine Breckpot
Archivum Immunologiae Et Therapiae Experimentalis|February 10, 2010
Lentiviral vectors in gene therapy: their current status and future potentialDavid Escors, Karine Breckpot
Journal of Immunology Research|November 20, 2015
Pros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesCleo Goyvaerts, Karine Breckpot
Frontiers in Cell and Developmental Biology|August 17, 2019
Commentary: Immunogenic Cell Death and Immunotherapy of Multiple MyelomaKen Maes, Karine Breckpot
International Review of Cell and Molecular Biology|January 15, 2024
Novel technologies for applying immune checkpoint blockersRobin Maximilian Awad, Karine Breckpot
Immunotherapy|May 11, 2011
mRNA: delivering an antitumor message?Sandra Van Lint, Kris Thielemans, Karine Breckpot
Current Gene Therapy|December 17, 2008
Lentiviral vectors for anti-tumor immunotherapyKarine Breckpot, Perpetua U Emeagi, Kris Thielemans
Oncoimmunology|November 20, 2012
The role of SMAC mimetics in regulation of tumor cell death and immunityPerpetua U Emeagi, Kris Thielemans, Karine Breckpot
Pageof 16